Business Wire

Bryan, Garnier & Co Makes Significant Move into the Nordics with the Acquisition of Beringer Finance

Del

Today, Bryan, Garnier & Co announced the acquisition of Beringer Finance and the expansion of its partnership. Beringer Finance is a premier, Nordic-focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto. Throughout the past 10 years, Beringer Finance has advised on over 140 transactions, building a strong track record in the TMT, IT Services, and Fintech markets. The closing is subject to pending regulatory approvals and other customary closing conditions.

Olivier Garnier, Co-founder and Managing Partner of Bryan, Garnier & Co comments: “Bryan, Garnier & Co is an independent partnership that combines highly experienced, entrepreneur-minded investment banking professionals with the services and expertise of a top-tier investment bank. The culture of excellence at Beringer Finance and our shared ambition to expand will be a strong driver to accelerate Bryan, Garnier & Co’s development in the region, across our business lines and industry sectors. We are delighted to welcome Adalsteinn Johannsson and his team to lead this effort”.

“The Nordics is one of the main European Technology and Life Sciences hubs where we have longstanding client relationships” comments Greg Revenu, Managing Partner of Bryan, Garnier & Co. “This combination not only creates an exciting opportunity for the firm and its teams, but also a unique capacity to support the growth of our clients: it propels our Technology coverage to the next level, while opening a new challenge to our leading European healthcare franchise.”

“We are excited to be joining forces with Bryan, Garnier & Co” explains Adalsteinn Johannsson, CEO at Beringer Finance “Its full-service capacities combining investment banking and capital markets services provides us with the scale and resources to accelerate our growth. Bryan, Garnier & Co’s entrepreneurial DNA is a perfect match for the strong culture and unique approach we have built at Beringer. We very much look forward writing this journey together with this outstanding team.”

Beringer Finance will be operating under the Bryan, Garnier & Co brand with CEO Adalsteinn Johannsson joining Bryan, Garnier & Co as a partner focused on International M&A, with Beringer’s Tor Berthelius as a partner to lead the Nordic operations. Beringer’s 27 technology-focused bankers will be fully integrated with Bryan, Garnier & Co’s existing investment banking professionals, across its London, Paris, Munich, Stockholm, Oslo, Reykjavik, New York and Palo Alto offices. With a European technology group of more than 80 professionals, Bryan, Garnier & Co will benefit from an unmatched position in the European technology investment banking landscape.

RECENT ACHIEVEMENTS

Over the past 24 months, Bryan, Garnier & Co and Beringer Finance have led more than 85 transactions, including backing three of the most disruptive unicorns of 2018:

  • 47 international public and private M&A deals representing an aggregate value of approximately $2.4 billion, many of which involved tier one private equity investors and publicly-listed trade buyers. Recent deals include the sale of Sword Apak to Sopra Banking Software, the sale of Symetis to Boston Scientific for $435m, the sale of Dimelo to RingCentral, the sale of Prima Solutions to the Carlyle Group, the 30% sale of Advania to VIA equity and PFA, and the sale of Universum to Axel Springer company StepStone.
  • 25 growth capital private placements and PIPEs representing an aggregated amount raised of some $550 million, for companies such as blockchain unicorn Bitfury ($80m), biotech unicorn Moderna ($80m), Tado° ($50m), Highlife ($37m), Devialet ($210m), and BraBank ($35m).
  • 15 IPOs and public offerings on Nasdaq, NYSE, Euronext, and other major exchanges for an aggregated amount of more than $1.4 billion, including four deals led or co-led on Nasdaq or NYSE. Recent transactions include: representation of cannabis unicorn Canopy Growth ($450m, TMX, NYSE), Medartis ($138m, Swiss Exchange), Materialise ($52m, Nasdaq), Medigene ($56m, Deutsche Börse Group), Celyad ($53m, Nasdaq, Euronext) and Genfit ($155.4m, Nasdaq).

About Beringer Finance (www.beringerfinance.com)

Beringer Finance is a technology focused boutique investment bank with offices in Stockholm, Oslo, Reykjavik and Palo Alto. Tracing its roots back over 100 years, Beringer is continuously driven by the ambition to help companies and entrepreneurs strategically develop and grow their businesses while realizing their dreams and their aspirations.

Their expertise and market leadership have seen them advise top-tier clients on over 140 transactions in the past 10 years. Despite calling the Nordics its home, Beringer works across all continents and focuses on M&A and private placements after selling its Fondsfinans brokerage business in 2018.

About Bryan, Garnier & Co (www.bryangarnier.com)

Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorised and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich and New York. The firm is a member of the London Stock Exchange and Euronext.

Contact information

Press contact: Profile!
Caroline MATUSZEWSKI - Leslie BOUTIN- SOSSAH
+ 33 1 56 26 72 32 – 33
cmatuszewski@agence-profile.com
lboutin@agence-profile.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Nordson EFD Introduces the Contact versus Jet Dispensing White Paper25.4.2019 12:16:00 CESTPressemelding

Nordson EFD , a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, is pleased to introduce its Contact vs. Jet Dispensing white paper. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005027/en/ As products continue to get smaller and smaller, Nordson EFD has developed new solutions to address this growing need to apply precise, repeatable micro-deposits of assembly fluids in production processes worldwide. “We understand the challenges manufacturers face when their process requires bonding tiny substrates and components together,” said Peter Langer, Business Unit Director of Valves at Nordson EFD. “The deposit tolerance requirements are considerable. And there are a number of variables to consider in order to choose the right dispensing method.” This white paper helps manufacturers understand the difference between two of the most common dispensing methods. Contact dispe

Hologic Launches Trident® HD Specimen Radiography System in United States, Canada and Europe25.4.2019 12:15:00 CESTPressemelding

Hologic, Inc. (Nasdaq: HOLX) today announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005180/en/ Trident® HD Specimen Radiography System (Photo: Business Wire) The Trident products are the only specimen radiographs on the market to use amorphous selenium direct capture imaging – the same detector technology used in Hologic’s 3Dimensions™ mammography system – to generate crisp, clear, high-resolution images. The new Trident HD system, which recently received FDA clearance in the US and a CE Mark in Europe, also features a bigger detector that allows for complete imaging of larger breast surgical specimens, along with a wide range of surgical and biopsy sa

Velodyne Lidar, Nikon Announce Manufacturing Agreement for Mass Production of Velodyne Lidar Sensors25.4.2019 12:00:00 CESTPressemelding

Velodyne Lidar, Inc. today announced an agreement with Nikon Corporation, under which Sendai Nikon Corporation, a Nikon subsidiary, will manufacture lidar sensors for Velodyne with plans to start mass production in the second half of 2019. The partnership cements Velodyne’s manufacturing plan and expands its lead in the global lidar sensor market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190425005236/en/ Velodyne provides the smartest, most powerful lidar solutions for vehicle autonomy and driver assistance. (Photo: Business Wire) “Mass production of our high-performance lidar sensors is key to advancing Velodyne’s immediate plans to expand sales in North America, Europe, and Asia,” said Marta Hall, President and CBDO, Velodyne Lidar. “With this partnership, Velodyne affirms its leadership role in designing, producing, and selling lidar for worldwide implementation. For years, Velodyne has been perfecting lidar technol

Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH)25.4.2019 12:00:00 CESTPressemelding

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-3, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an investigational, once daily, oral inhibitor of apoptosis signal-regulating kinase 1 (ASK1), for patients with bridging fibrosis (F3) due to nonalcoholic steatohepatitis (NASH), did not meet the pre-specified week 48 primary endpoint of a ≥ 1-stage histologic improvement in fibrosis without worsening of NASH. In the study of 802 enrolled and dosed patients, 9.3 percent of patients treated with selonsertib 18 mg (p=0.42 versus placebo) and 12.1 percent of patients treated with selonsertib 6 mg (p=0.93) achieved a ≥ 1-stage improvement in fibrosis according to the NASH Clinical Research Network (CRN) classification without worsening of NASH after 48 weeks of treatment, versus 13.2 percent with placebo. Selonsertib was generally well tolerated and safety results were consistent with prior studies. “While we

Forter Readies Merchants with Launch of PSD2-Compliant Solution25.4.2019 11:25:00 CESTPressemelding

Forter, the leading e-commerce fraud prevention company, today launches its PSD2-compliant merchant offering, Forter PSD2 Solution for Merchants . The comprehensive, payment processor-agnostic solution enables merchants to dynamically route customers to the path of least friction required, prevent all types of fraud and violations of business policies, and optimise the customer’s payment experience – all while meeting full PSD2 compliance. As of 14 September 2019, the revised Payment Services Directive (PSD2) introduces the requirement for merchants to authenticate online transactions within the European Economic Area using Strong Customer Authentication (SCA). Under SCA, merchants have to introduce additional friction into the purchasing process for customers, which will lead to increased drop-off rates, reduce overall conversion rates, and provide a poor customer experience. These changes could ultimately hurt revenue, so merchants must mitigate these challenges and minimise the impa

The Smarter E Europe – Explore Sector Coupling for Yourself at Europe’s Largest Platform for the Energy Industry25.4.2019 09:53:00 CESTPressemelding

The innovation hub The smarter E Europe, encompassing the exhibitions Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power, was launched in 2018 and has seen impressive growth ever since. It will be held for the second time from May 15–17, 2019 at Messe München and will now cover 10 exhibition halls, making it Europe’s largest energy industry event. This growth is due in large part to the upward trend in renewable energies. Since 2010, the proportion of energy generated worldwide from renewable sources has risen from 20 to 25 percent. By 2030, we’re looking at a jump to around 60 percent. In Germany, an average of 45 percent of all electricity generated already came from renewables in the first quarter of 2019. This dynamism is stimulating innovation and shaping the modern energy industry. The buzzword of the hour is sector coupling – a unification of the previously independent electricity, heating and transportation sectors. For instance, a photovoltaic (PV) installation in